Trilogy Capital Inc. Becton Dickinson & CO Transaction History
Trilogy Capital Inc.
- $2.15 Billion
- Q3 2025
A detailed history of Trilogy Capital Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Trilogy Capital Inc. holds 1,332 shares of BDX stock, worth $254,385. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,332
Previous 1,379
3.41%
Holding current value
$254,385
Previous $237,000
5.06%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BDX
# of Institutions
1,717Shares Held
257MCall Options Held
1.01MPut Options Held
544K-
Vanguard Group Inc Valley Forge, PA32.5MShares$6.2 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.25 Billion0.12% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$3.1 Billion1.86% of portfolio
-
State Street Corp Boston, MA13.9MShares$2.65 Billion0.09% of portfolio
-
First Eagle Investment Management, LLC9.99MShares$1.91 Billion3.54% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $54.5B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...